Michel Gilliet

Michel Gilliet

Auto-generated profile, based on publicly available information

Michel Gilliet

Department of Dermatology, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2011 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
Roberto LandeRoberto Lande
Roberto Lande
DGDipyaman Ganguly
Dipyaman Ganguly
VFValeria Facchinetti
Valeria Facchinetti
Loredana FrascaLoredana Frasca
Loredana Frasca
CCCurdin Conrad
Curdin Conrad
MGMichel Gilliet
Michel Gilliet
In systemic lupus erythematosus, neutrophils release peptide/self-DNA complexes that trigger plasmacytoid dendritic cell activation and autoantibody formation.

19 January 2022 in Nature
Verified
Journal Article
Open access
PDF file
JDJeremy Di Domizio
Jeremy Di Domizio
MGMuhammet F. Gulen
Muhammet F. Gulen
FSFanny Saidoune
Fanny Saidoune
VTVivek Vijay Thacker
Vivek Vijay Thacker
AYAhmad Yatim
Ahmad Yatim
AAAndrea Ablasser
Andrea Ablasser
COVID-19, which is caused by infection with SARS-CoV-2, is characterized by lung pathology and extrapulmonary complications1,2. Type I interferons (IFNs) have an essential role in the pathogenesis of COVID-19 (refs 3–5). Although rapid induction of type I IFNs limits virus propagation, a sustained increase in the levels of type I IFNs in the late phase of the infection is associated with aberrant inflammation and poor clinical outcome5–17. Here we show that the cyclic GMP-AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway, which controls immunity to cytosolic DNA, is a critical driver of aberrant type I IFN responses in COVID-19 (ref. 18). Profiling COVID-19 skin manifestations, we uncover a STING-dependent type I IFN signature that is primarily mediated by macrophages adjacent to areas of endothelial cell damage. Moreover, cGAS–STING activity was detected in lung samples from patients with COVID-19 with prominent tissue destruction, and was associated with type I IFN responses. A lung-on-chip model revealed that, in addition to macrophages, infection with SARS-CoV-2 activates cGAS–STING signalling in endothelial cells through mitochondrial DNA release, which leads to cell death and type I IFN production. In mice, pharmacological inhibition of STING reduces severe lung inflammation induced by SARS-CoV-2 and improves disease outcome. Collectively, our study establishes a mechanistic basis of pathological type I IFN responses in COVID-19 and reveals a principle for the development of host-directed therapeutics.

25 November 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ODOlivier Demaria
Olivier Demaria
AGAude De Gassart
Aude De Gassart
SCSanja Coso
Sanja Coso
NGNicolas Gestermann
Nicolas Gestermann
JDJeremy Di Domizio
Jeremy Di Domizio
MGMichel Gilliet
Michel Gilliet
Significance: Tumor recognition by the immune system can occur spontaneously but has usually little impact on tumor growth. However, the cellular and molecular mechanisms that drive these responses could be exploited therapeutically to generate efficacious antitumor immunity. Here, we show that stimulator of IFN genes (STING), a molecule involved in cytosolic DNA sensing and required for the generation of spontaneous antitumor immune responses, can be targeted by intratumoral injection of cGAMP to boost antitumor immunity and to control tumor growth. The immune response induced by therapeutic but also spontaneous STING activation was dependent on type I IFN produced by endothelial cells in the tumor microenvironment, unraveling an unexpected role of the tumor vasculature in the initiation of spontaneous and therapeutic antitumor immunity via STING.

29 November 2010 in Journal of Experimental Medicine
Verified
Journal Article
Open access
JGJosh Gregorio
Josh Gregorio
SMStephan Meller
Stephan Meller
CCCurdin Conrad
Curdin Conrad
ANAnna Di Nardo
Anna Di Nardo
BHBernhard Homey
Bernhard Homey
MGMichel Gilliet
Michel Gilliet
Plasmacytoid dendritic cells (pDCs) are specialized type I interferon (IFN-α/β)–producing cells that express intracellular toll-like receptor (TLR) 7 and TLR9 and recognize viral nucleic acids in the context of infections. We show that pDCs also have the ability to sense host-derived nucleic acids released in common skin wounds. pDCs were found to rapidly infiltrate both murine and human skin wounds and to transiently produce type I IFNs via TLR7- and TLR9-dependent recognition of nucleic acids. This process was critical for the induction of early inflammatory responses and reepithelization of injured skin. Cathelicidin peptides, which facilitate immune recognition of released nucleic acids by promoting their access to intracellular TLR compartments, were rapidly induced in skin wounds and were sufficient but not necessary to stimulate pDC activation and type I IFN production. These data uncover a new role of pDCs in sensing tissue damage and promoting wound repair at skin surfaces.

12 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
FMFeiyang Ma
Feiyang Ma
OPOlesya Plazyo
Olesya Plazyo
ABAllison C. Billi
Allison C. Billi
LTLam C. Tsoi
Lam C. Tsoi
XXXianying Xing
Xianying Xing
JGJohann Gudjonsson
Johann Gudjonsson
The immunopathogenesis of psoriasis, a common chronic inflammatory disease of the skin, is incompletely understood. Here we demonstrate, using a combination of single cell and spatial RNA sequencing, IL-36 dependent amplification of IL-17A and TNF inflammatory responses in the absence of neutrophil proteases, which primarily occur within the supraspinous layer of the psoriatic epidermis. We further show that a subset of SFRP2+ fibroblasts in psoriasis contribute to amplification of the immune network through transition to a pro-inflammatory state. The SFRP2+ fibroblast communication network involves production of CCL13, CCL19 and CXCL12, connected by ligand-receptor interactions to other spatially proximate cell types: CCR2+ myeloid cells, CCR7+LAMP3+ dendritic cells, and CXCR4 expressed on both CD8+ Tc17 cells and keratinocytes, respectively. The SFRP2+ fibroblasts also express cathepsin S, further amplifying inflammatory responses by activating IL-36G in keratinocytes. These data provide an in-depth view of psoriasis pathogenesis, which expands our understanding of the critical cellular participants to include inflammatory fibroblasts and their cellular interactions.

14 October 2012 in Cancer Research
Verified
Journal Article
Closed access
PDF file
CCCurdin Conrad
Curdin Conrad
JGJosh Gregorio
Josh Gregorio
YWYi-Hong Wang
Yi-Hong Wang
TITomoki Ito
Tomoki Ito
SMStephan Meller
Stephan Meller
MGMichel Gilliet
Michel Gilliet
Epithelial ovarian cancer (EOC) is the fifth most common cause of cancer death among women. Despite its immunogenicity, effective antitumor responses are limited, due, in part, to the presence of forkhead box protein 3–positive (Foxp3+) T regulatory (Treg) cells in the tumor microenvironment. However, the mechanisms that regulate the accumulation and the suppressive function of these Foxp3+ Treg cells are poorly understood. Here, we found that the majority of Foxp3+ Treg cells accumulating in the tumor microenvironment of EOCs belong to the subset of Foxp3+ Treg cells expressing inducible costimulator (ICOS). The expansion and the suppressive function of these cells were strictly dependent on ICOS-L costimulation provided by tumor plasmacytoid dendritic cells (pDC). Accordingly, ICOS+ Foxp3+ Treg cells were found to localize in close vicinity of tumor pDCs, and their number directly correlated with the numbers of pDCs in the tumors. Furthermore, pDCs and ICOS+ Foxp3+ Treg cells were found to be strong predictors for disease progression in patients with ovarian cancer, with ICOS+ Treg cell subset being a stronger predictor than total Foxp3+ Treg cells. These findings suggest an essential role for pDCs and ICOS-L in immunosuppression mediated by ICOS+ Foxp3+ Treg cells, leading to tumor progression in ovarian cancer. Cancer Res; 72(20); 5240–9. ©2012 AACR.